From the The Parker Institute, Bispebjerg and Frederiksberg Hospital.
Department of Radiology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Invest Radiol. 2021 Jul 1;56(7):417-424. doi: 10.1097/RLI.0000000000000756.
The aim of this study was to determine the diagnostic performance of dual-energy computed tomography (DECT) to detect and distinguish crystal deposits in a phantom. The primary objective was to determine the cutoff DECT ratio and the cross-sectional area (CSA) of a crystal deposit necessary to differentiate monosodium urate (MSU), calcium pyrophosphate (CPP), and calcium hydroxyapatite (HA) using DECT. Our secondary objective was to determine the concentration for limit of detection for MSU, CPP, and HA crystal deposits. Exploratory objectives included the comparison between 2 generations of DECT scanners from the same manufacturer as well as different scanner settings.
We used a cylindrical soft tissue phantom with synthetic MSU, CPP, and HA crystals suspended in resin. Crystal suspension concentration increased with similar attenuation between MSU, CPP, and HA in conventional CT. The phantom was scanned on 2 dual-source DECT scanners, at 2 dose levels and all available tube voltage combinations. Both scanners had a tin (Sn) filter at the high-energy spectra. Dual-energy CT ratios were calculated for a given tube voltage combination by dividing linear regression lines of CT numbers against concentration. Dual-energy CT ratios were compared using an analysis of covariance. Receiver operating characteristic curves and corresponding areas under the curve (AUCs) were calculated for individual crystal suspension comparisons (HA vs CPP, MSU vs CPP, and MSU vs HA).
At standard clinical scan settings with 8 mGy and 80/Sn150 kV, the DECT ratios were as follows: CPP, 2.02 (95% confidence interval [CI], 1.98-2.07); HA, 2.00 (95% CI, 1.96-2.05); and MSU, 1.09 (95% CI, 1.06-1.11). Ratios varied numerically depending on the scanner and tube voltage combination. Monosodium urate crystal DECT ratios were significantly different from HA and CPP (P < 0.001), whereas DECT ratios for HA and CPP crystals did not differ significantly (P = 0.99). The differentiation of MSU crystals from both calcium crystals (HA and CPP) was excellent with an AUC of 1.00 (95% CI, 1.00-1.00) and an optimal cutoff DECT ratio of 1.43:1.40 depending on the scanner. In addition, differentiation of MSU and calcium-containing crystals (HA and CPP) required a CSA of minimum 4 pixels of crystal at standard clinical scan conditions. In contrast, differentiation between CPP and HA crystals was moderate with AUCs ranging from 0.66 (95% CI, 0.52-0.80) to 0.80 (95% CI, 0.69-0.91) and an optimal cutoff DECT ratio of 2.02:2.06 depending on the scanner. Furthermore, differentiation between CPP and HA crystals required a CSA of minimum 87 pixels of crystal at standard clinical scan conditions, corresponding to a region of interest of 3.7 mm diameter. When scanning at highest possible spectral separation and maximum dose of 50 mGy, the limit of detection for crystals within a region of interest of 50 pixels was 14 mg/cm3 for MSU and 2 mg/cm3 for both CPP and HA.
This phantom study shows that DECT can be used to detect MSU, CPP, and HA crystal deposits. Differentiation of CPP and HA was not possible in crystals deposits less than 3.7 mm in diameter, but MSU could accurately be differentiated from CPP and HA crystal deposits at standard clinical scan conditions.
本研究旨在确定双能计算机断层扫描(DECT)检测和区分仿体中晶体沉积物的诊断性能。主要目的是确定使用 DECT 区分单钠尿酸盐(MSU)、焦磷酸钙(CPP)和羟磷灰石(HA)所需的 DECT 比值和晶体沉积物的横截面积(CSA)的截止值。我们的次要目标是确定 MSU、CPP 和 HA 晶体沉积物的检测限浓度。探索性目标包括比较来自同一制造商的两代 DECT 扫描仪以及不同的扫描仪设置。
我们使用了一个圆柱形软组织仿体,其中悬浮有合成的 MSU、CPP 和 HA 晶体。晶体悬浮液的浓度与常规 CT 中 MSU、CPP 和 HA 之间的相似衰减增加。在 2 台双源 DECT 扫描仪上以 2 个剂量水平和所有可用的管电压组合对该仿体进行扫描。两台扫描仪的高能谱线上均有锡(Sn)滤光片。通过将 CT 号与浓度的线性回归线相除,计算出给定管电压组合的双能 CT 比值。使用协方差分析比较双能 CT 比值。对于每个晶体悬浮液比较(HA 与 CPP、MSU 与 CPP 和 MSU 与 HA),计算了受试者工作特征曲线和相应的曲线下面积(AUC)。
在标准临床扫描设置(8 mGy 和 80/Sn150 kV)下,DECT 比值如下:CPP,2.02(95%置信区间 [CI],1.98-2.07);HA,2.00(95% CI,1.96-2.05);MSU,1.09(95% CI,1.06-1.11)。比值根据扫描仪和管电压组合在数值上有所不同。MSU 晶体的 DECT 比值与 HA 和 CPP 明显不同(P<0.001),而 HA 和 CPP 晶体的 DECT 比值没有显著差异(P=0.99)。MSU 晶体与两种钙晶体(HA 和 CPP)的区分具有极好的 AUC 为 1.00(95% CI,1.00-1.00)和最佳截止 DECT 比值为 1.43:1.40,具体取决于扫描仪。此外,在标准临床扫描条件下,MSU 和含钙晶体(HA 和 CPP)的区分需要 CSA 最小为 4 个晶体像素。相比之下,CPP 和 HA 晶体之间的区分中等,AUC 范围为 0.66(95% CI,0.52-0.80)至 0.80(95% CI,0.69-0.91),最佳截止 DECT 比值取决于扫描仪为 2.02:2.06。此外,在标准临床扫描条件下,CPP 和 HA 晶体之间的区分需要 CSA 最小为 87 个晶体像素,对应于感兴趣区域为 3.7 毫米直径。当以最大光谱分离和最大剂量 50 mGy 进行扫描时,50 像素感兴趣区域内晶体的检测限为 MSU 为 14 mg/cm3,CPP 和 HA 均为 2 mg/cm3。
这项仿体研究表明,DECT 可用于检测 MSU、CPP 和 HA 晶体沉积物。在直径小于 3.7 毫米的晶体沉积物中,CPP 和 HA 之间的区分是不可能的,但在标准临床扫描条件下,MSU 可以准确地区分 CPP 和 HA 晶体沉积物。